Bulk Manufacturer of Controlled Substances Application: Cedarburg Pharmaceuticals, 10820 [2022-04064]
Download as PDF
<![CDATA[
10820
ACTION:
Federal Register / Vol. 87, No. 38 / Friday, February 25, 2022 / Notices
Notice of application.
DEPARTMENT OF JUSTICE
S&B Pharma LLC has applied
to be registered as a bulk manufacturer
of basic class(es) of controlled
substance(s). Refer to Supplemental
Information listed below for further
drug information.
SUMMARY:
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before April 26, 2022. Such persons
may also file a written request for a
hearing on the application on or before
April 26, 2022.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
ADDRESSES:
In
accordance with 21 CFR 1301.33(a), this
is notice that on December 24, 2021,
S&B Pharma LLC, 405 South Motor
Avenue, Azusa, California 91702,
applied to be registered as a bulk
manufacturer of the following basic
class(es) of controlled substance(s):
SUPPLEMENTARY INFORMATION:
Controlled substance
lotter on DSK11XQN23PROD with NOTICES1
Gamma Hydroxybutyric
Acid.
Marihuana .....................
Tetrahydrocannabinols
Amphetamine ...............
Methamphetamine ........
Lisdexamfetamine ........
Methylphenidate ...........
Pentobarbital ................
4-Anilino-N-Phenethyl4-Piperidine (ANPP).
Tapentadol ....................
Fentanyl ........................
Drug
code
Schedule
2010
I
7360
7370
1100
1105
1205
1724
2270
8333
I
I
II
II
II
II
II
II
9780
9801
II
II
The company plans to bulk
manufacture the listed controlled
substances for the internal use
intermediates for formulation and
analytical development purposes or for
sale to its customers. In reference to dug
codes 7360 (Marihuana), and 7370
(Tetrahydrocannabinols), the company
plans to bulk manufacture these drugs
as synthetic. No other activities for these
drug codes are authorized for this
registration.
Matthew J. Strait,
Deputy Assistant Administrator.
[FR Doc. 2022–04062 Filed 2–24–22; 8:45 am]
BILLING CODE 4410–09–P
VerDate Sep<11>2014
16:44 Feb 24, 2022
Jkt 256001
Controlled substance
Drug
code
Schedule
Drug Enforcement Administration
[Docket No. DEA–974]
Bulk Manufacturer of Controlled
Substances Application: Cedarburg
Pharmaceuticals
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Cedarburg Pharmaceuticals
has applied to be registered as a bulk
manufacturer of basic class(es) of
controlled substance(s). Refer to
Supplemental Information listed below
for further drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before April 26, 2022. Such persons
may also file a written request for a
hearing on the application on or before
April 26, 2022.
ADDRESSES: DEA requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to https://
www.regulations.gov and follow the
online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.’’
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.33(a), this
is notice that on August 27, 2021,
Cedarburg Pharmaceuticals, 870 Badger
Circle, Grafton, Wisconsin 53024–0000,
applied to be registered as a bulk
manufacturer of the following basic
class(es) of controlled substance(s):
SUMMARY:
Controlled substance
Lysergic Acid
Diethylamide.
Tetrahydrocannabinols
4-Bromo-2,5Dimethoxyphenethylamine.
3,4Methylenediocyamphetamine.
PO 00000
Frm 00057
Fmt 4703
Drug
code
Schedule
7315
I
7370
7392
I
I
7400
I
Sfmt 4703
3.4Methylenedioxymethamphetamine.
5-Methoxy-N-Ndimethltryptamine.
Dimethyltryptamine .......
Psilocybin .....................
Psilocyn ........................
Methylphenidate ...........
Nabilone .......................
4-Anilino-N-Phenethyl4-Piperidine (ANPP).
Fentanyl ........................
7405
I
7431
I
7435
7437
7438
1724
7379
8333
I
I
I
II
II
II
9801
II
The company plans to bulk
manufacture the listed controlled
substances for the internal use
intermediates or for sale to its
customers. In reference to the drug code
7370 (Tetrahydrocannabinols), the
company plans to bulk manufacture as
synthetic. No other activity for this drug
code is authorized for this registration.
Matthew J. Strait,
Deputy Assistant Administrator.
[FR Doc. 2022–04064 Filed 2–24–22; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–964]
Bulk Manufacturer of Controlled
Substances Application: Synthcon
LLC
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Synthcon LLC has applied to
be registered as a bulk manufacturer of
basic class(es) of controlled
substance(s). Refer to SUPPLEMENTAL
INFORMATION listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before April 26, 2022. Such persons
may also file a written request for a
hearing on the application on or before
April 26, 2022.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
SUMMARY:
In
accordance with 21 CFR 1301.33(a), this
is notice that on December 2, 2021,
SUPPLEMENTARY INFORMATION:
E:\FR\FM\25FEN1.SGM
25FEN1
]]>Agencies
[Federal Register Volume 87, Number 38 (Friday, February 25, 2022)]
[Notices]
[Page 10820]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-04064]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-974]
Bulk Manufacturer of Controlled Substances Application: Cedarburg
Pharmaceuticals
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Cedarburg Pharmaceuticals has applied to be registered as a
bulk manufacturer of basic class(es) of controlled substance(s). Refer
to Supplemental Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before April 26, 2022.
Such persons may also file a written request for a hearing on the
application on or before April 26, 2022.
ADDRESSES: DEA requires that all comments be submitted electronically
through the Federal eRulemaking Portal, which provides the ability to
type short comments directly into the comment field on the web page or
attach a file for lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for
submitting comments. Upon submission of your comment, you will receive
a Comment Tracking Number. Please be aware that submitted comments are
not instantaneously available for public view on https://www.regulations.gov. If you have received a Comment Tracking Number,
your comment has been successfully submitted and there is no need to
resubmit the same comment.''
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on August 27, 2021, Cedarburg Pharmaceuticals, 870
Badger Circle, Grafton, Wisconsin 53024-0000, applied to be registered
as a bulk manufacturer of the following basic class(es) of controlled
substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Lysergic Acid Diethylamide............. 7315 I
Tetrahydrocannabinols.................. 7370 I
4-Bromo-2,5-Dimethoxyphenethylamine.... 7392 I
3,4-Methylenediocyamphetamine.......... 7400 I
3.4-Methylenedioxymethamphetamine...... 7405 I
5-Methoxy-N-N-dimethltryptamine........ 7431 I
Dimethyltryptamine..................... 7435 I
Psilocybin............................. 7437 I
Psilocyn............................... 7438 I
Methylphenidate........................ 1724 II
Nabilone............................... 7379 II
4-Anilino-N-Phenethyl-4-Piperidine 8333 II
(ANPP).
Fentanyl............................... 9801 II
------------------------------------------------------------------------
The company plans to bulk manufacture the listed controlled
substances for the internal use intermediates or for sale to its
customers. In reference to the drug code 7370 (Tetrahydrocannabinols),
the company plans to bulk manufacture as synthetic. No other activity
for this drug code is authorized for this registration.
Matthew J. Strait,
Deputy Assistant Administrator.
[FR Doc. 2022-04064 Filed 2-24-22; 8:45 am]
BILLING CODE 4410-09-P
